Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering.
about
Impact of IgG Fc-Oligosaccharides on Recombinant Monoclonal Antibody Structure, Stability, Safety, and Efficacy.Glycosylation of IgG-Fc: a molecular perspective.Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.Biologics: structural heterogeneity and immunogenicity.Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy.Microheterogeneity of Recombinant Antibodies: Analytics and Functional Impact.Capillary Electrophoresis Separations of Glycans.
P2860
Q38762019-A92260E1-AF79-4D11-89B6-70CD75E9A5DAQ39401108-FEC8C992-3E63-4A0C-8619-314227A94D24Q42372842-9F0E7C99-973A-41BA-BCE2-A27C321791B8Q44852748-573521CE-8E3D-4EB2-99B9-1D5838A8B81EQ47983376-10CFD8CA-72EA-4EAF-A06C-286BAEE6FE06Q49592680-C8013694-2061-46ED-8984-7E0C5AEAB3CDQ50237001-66D59F46-1825-4E47-A710-49E7C7743D47Q52660979-898FEAC9-F93E-4878-BF0A-7F8C76C2F1FD
P2860
Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering.
@en
Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering.
@nl
type
label
Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering.
@en
Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering.
@nl
prefLabel
Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering.
@en
Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering.
@nl
P2860
P50
P1433
P1476
Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering
@en
P2093
Xiaojie Yu
P2860
P2888
P304
P356
10.1007/S40259-017-0223-8
P577
2017-06-01T00:00:00Z